logo
Plus   Neg
Share
Email

Regeneron, Zoetis Announce Research Collaboration - Quick Facts

Regeneron Pharmaceuticals, Inc. (REGN) and Zoetis Inc. (ZTS) announced a five-year collaboration to research the use of Regeneron's monoclonal antibody therapeutics in animals and discover new veterinary treatments. Regeneron has granted Zoetis a license for its VelocImmune antibody technology, which Zoetis will use to develop monoclonal antibodies modified for species-specific use in companion and livestock animals.

Regeneron will receive a license fee, approval and sales milestone payments and royalties on any potential veterinary treatments.

For comments and feedback contact: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Sears Holding Corp. Chairman Eddie Lampert won a bankruptcy auction for the struggling department store chain that will keep it in business, reports said citing people familiar with the matter. Lampert reportedly submitted an improved bid for the parent company of Kmart and Sears chains through his hedge fund ESL Investments. Bank of America (BAC) reported fourth-quarter net income of $7.3 billion, up 208% from prior year, driven by continued strong operating leverage and asset quality, as well as the benefit of tax reform impacting 2018. Fourth-quarter net income was up 39% adjusting for the impact of the Tax Act in prior... IBM said it joined with Ford Motor Co., Huayou Cobalt, LG Chem and RCS Global to launch a blockchain pilot program to trace and validate ethically sourced minerals. Separately, IBM has collaborated with mining technology company MineHub Technologies, Inc. for a blockchain technology-based solution to use in the global mining and metals supply chain.
Follow RTT